Colorectal Cancer
Medix Biochemica licenses CEA antibody technology
Published in Cancer Weekly, December 3rd, 2002
These patents cover antibodies that specifically recognize CEA, one of the most widely used markers for colorectal and other cancers. Under the license agreement, Medix Biochemica agreed to pay an up-front payment and royalties, as well as back-royalties and interest to Immunomedics for prior use of the patented technologies.
As a licensee, Medix Biochemica will now be permitted to use the patents worldwide for in vitro immunodiagnostics used for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2002-12-03)
More Articles from Cancer Weekly
- Cancer Screening
Geographic region of residence more than race affects rates - Hepatocellular Carcinoma
New evidence disfavors tamoxifen for primary liver cancer - Breast Cancer Screening
New technique lets doctors examine milk ducts for breast problems - Cancer Prevention
Team pioneers tests of new drug with 'red wine compound.' - Cancer Vaccine
Herpes amplicon vectors used to develop vaccines against metastatic liver cancer - Ewing Sarcoma
Interesting lead found in treatment - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
